Brain tumors can be helped with the implementation of certain drugs but what does this entail, one has to wonder? It's apparent that there are drugs which have been utilized to help separate conditions in the past but I'd like to think that there are those which are entirely unique. Whatever the case may be, there is potential to consider with the results that they can bring to the surface. Is it possible that further results can come about because of a particular two-drug tandem?
According to an article on YottaFire, it appears as though this is the case, as a new combination of drugs has been put to use in order to help slow down the growth rate of brain tumors. The study was conducted through a group of mice in order to see how well their survival rates have become. Fortunately, results were positive, as their levels of survival were made even greater. This is just the start as to why such a story is worthy of the attention of organizations such as Voices against Brain Cancer.
Dana-Farber Cancer Institute put together the study and it was determined that a combination of two drugs working together could play positively into the actions of glioblastoma. With this particular tandem, it would be able to focus on two cell signaling pathways. A previous study was done but it was deemed unsuccessful because of how only one pathway was focused on. While this improvement is worthy of note, what is more worthy has got to be a certain abnormality that is typical amongst one-third of glioblastoma patients.
These patients, from what I have gathered, seem to lack a certain gene by the name of PTEN. This may not be a common name to most but be certain that this gene works as something of a tumor-suppressant. If PTEN is not seen in the body, an excessive amount of molecular growth can occur, which means that the malignant rate of said growth can reach the brain as well. It is uncertain if PTEN can be replaced but the drug combination spoken about before can halt the level of growth seen.
With this in mind, it is important to make note of all of the occurrences that can be seen in the human body. Not all of them are going to make sense but it's apparent that they work together in order to create order. When a single element is out of place, though, the risk for contracting a condition can increase; this was proven by the potential lack of the PTEN gene. With certain drugs coming together and then going on to become implemented, though, the research focused on brain tumors can be given more essential information.
According to an article on YottaFire, it appears as though this is the case, as a new combination of drugs has been put to use in order to help slow down the growth rate of brain tumors. The study was conducted through a group of mice in order to see how well their survival rates have become. Fortunately, results were positive, as their levels of survival were made even greater. This is just the start as to why such a story is worthy of the attention of organizations such as Voices against Brain Cancer.
Dana-Farber Cancer Institute put together the study and it was determined that a combination of two drugs working together could play positively into the actions of glioblastoma. With this particular tandem, it would be able to focus on two cell signaling pathways. A previous study was done but it was deemed unsuccessful because of how only one pathway was focused on. While this improvement is worthy of note, what is more worthy has got to be a certain abnormality that is typical amongst one-third of glioblastoma patients.
These patients, from what I have gathered, seem to lack a certain gene by the name of PTEN. This may not be a common name to most but be certain that this gene works as something of a tumor-suppressant. If PTEN is not seen in the body, an excessive amount of molecular growth can occur, which means that the malignant rate of said growth can reach the brain as well. It is uncertain if PTEN can be replaced but the drug combination spoken about before can halt the level of growth seen.
With this in mind, it is important to make note of all of the occurrences that can be seen in the human body. Not all of them are going to make sense but it's apparent that they work together in order to create order. When a single element is out of place, though, the risk for contracting a condition can increase; this was proven by the potential lack of the PTEN gene. With certain drugs coming together and then going on to become implemented, though, the research focused on brain tumors can be given more essential information.
About the Author:
If you'd like to uncover further information about brain tumors, take a moment to visit Voices against Brain Cancer. Check here for free reprint license: Brain Tumors & The Usage Of A Two-Drug Tandem.
0 commentaires:
Post a Comment
Thanks for your comment.